Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.13 trillion and total revenue of $106.67 billion.
Market Cap
1.13T
Revenue
106.67B
Profits
-42.35B
PE Ratio
n/a
Profit Margin
-39.70%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 118.89B | -1.95% | 243,133 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.49B | 0.07% | 66,652 | 14.34B |
| 3 | ARGX | argenx SE | 51.41B | -0.32% | 54,364 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.50B | 0.89% | 346,496 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 39.18B | -0.22% | 16,687 | 4.97B |
| 6 | INSM | Insmed Incorporated | 32.76B | 2.06% | 307,673 | 447.02M |
| 7 | BNTX | BioNTech SE | 27.07B | 0.84% | 77,509 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 25.98B | -0.81% | 324,085 | 2.38B |
| 9 | INCY | Incyte Corporation | 20.36B | 1.15% | 283,775 | 5.14B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.97B | 2.99% | 665,981 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.32B | -0.65% | 235,675 | - |
| 12 | GMAB | Genmab A/S | 19.05B | -3.27% | 1,091,136 | 3.72B |
| 13 | MRNA | Moderna, Inc. | 18.18B | 5.90% | 5,581,342 | 1.94B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.73B | 0.79% | 337,359 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.89B | 1.30% | 77,544 | 845.52M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.44B | 2.02% | 235,551 | 966.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.38B | 2.36% | 293,946 | - |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.60B | 0.72% | 152,364 | 3.09B |
| 19 | EXEL | Exelixis, Inc. | 11.38B | -0.64% | 418,641 | 2.32B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.23B | 1.49% | 53,864 | 740.64M |
| 21 | RNA | Avidity Biosciences, Inc. | 10.98B | -0.03% | 594,751 | 20.87M |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 10.17B | -0.32% | 77,444 | 4.16B |
| 23 | ABVX | ABIVAX Société Anonyme | 9.94B | 2.68% | 406,507 | 6.23M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.32B | 0.89% | 41,790 | 561.26M |
| 25 | TECH | Bio-Techne Corporation | 9.24B | 0.92% | 313,518 | 1.22B |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.21B | 1.19% | 59,911 | 7.46M |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.07B | 1.72% | 256,082 | 1.09B |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.76B | -7.41% | 1,409,037 | 1.40B |
| 29 | CYTK | Cytokinetics, Incorporated | 8.26B | 1.38% | 193,536 | 87.21M |
| 30 | KRYS | Krystal Biotech, Inc. | 8.18B | -2.03% | 78,045 | 389.13M |
| 31 | PCVX | Vaxcyte, Inc. | 7.96B | 3.96% | 197,993 | - |
| 32 | NUVL | Nuvalent, Inc. | 7.95B | 0.10% | 51,007 | - |
| 33 | IBRX | ImmunityBio, Inc. | 7.46B | 25.75% | 22,601,128 | 82.56M |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.84B | 0.03% | 60,899 | 174.33M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.78B | -0.04% | 77,906 | 43.74M |
| 36 | BLTE | Belite Bio, Inc | 6.66B | 1.00% | 19,883 | - |
| 37 | MIRM | Mirum Pharmaceuticals, Inc. | 6.35B | 3.08% | 70,634 | 471.79M |
| 38 | CAI | Caris Life Sciences, Inc. | 6.09B | 3.85% | 243,547 | 649.06M |
| 39 | COGT | Cogent Biosciences, Inc. | 5.79B | 1.18% | 1,322,709 | - |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.57B | 0.30% | 145,376 | 1.78B |
| 41 | IMVT | Immunovant, Inc. | 5.49B | 2.66% | 222,174 | - |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 5.19B | 0.67% | 39,388 | 209.22M |
| 43 | CRSP | CRISPR Therapeutics AG | 5.13B | 0.60% | 196,384 | 3.51M |
| 44 | CELC | Celcuity Inc. | 4.97B | 0.07% | 75,231 | - |
| 45 | GPCR | Structure Therapeutics Inc. | 4.87B | -1.30% | 143,565 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 4.78B | 0.82% | 118,397 | - |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.71B | 0.26% | 49,818 | - |
| 48 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.57B | 1.97% | 130,587 | 1.54M |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.50B | 0.17% | 709,843 | 598.70M |
| 50 | CGON | CG Oncology, Inc. | 4.43B | 2.02% | 131,746 | 2.17M |
| 51 | TERN | Terns Pharmaceuticals, Inc. | 4.36B | 1.34% | 314,396 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.25B | -0.03% | 133,278 | 531.90M |
| 53 | CORT | Corcept Therapeutics Incorporated | 4.22B | 1.31% | 124,458 | 741.17M |
| 54 | NAMS | NewAmsterdam Pharma Company N.V. | 4.19B | 4.74% | 335,953 | 22.50M |
| 55 | ACLX | Arcellx, Inc. | 4.08B | 0.63% | 71,004 | 35.90M |
| 56 | ERAS | Erasca, Inc. | 3.93B | 1.93% | 370,610 | - |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 3.88B | - | 143,270 | 1.05B |
| 58 | ADMA | ADMA Biologics, Inc. | 3.82B | 0.50% | 385,466 | 488.56M |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 3.73B | 0.99% | 14,948 | 251.23M |
| 60 | CNTA | Centessa Pharmaceuticals plc | 3.67B | 0.72% | 57,373 | 15.00M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.53B | 0.23% | 424,347 | - |
| 62 | ALMS | Alumis Inc. | 3.40B | 2.52% | 144,511 | 22.12M |
| 63 | LEGN | Legend Biotech Corporation | 3.36B | 0.41% | 150,878 | 909.05M |
| 64 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | 1.88% | 224,986 | 317.93M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.29B | 2.30% | 116,451 | 7.50M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.26B | 2.34% | 113,094 | - |
| 67 | VERA | Vera Therapeutics, Inc. | 3.14B | 3.15% | 122,232 | - |
| 68 | LQDA | Liquidia Corporation | 3.08B | 4.64% | 653,322 | 69.22M |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.03B | 0.20% | 152,300 | 578.20M |
| 70 | DNLI | Denali Therapeutics Inc. | 3.00B | -0.41% | 240,697 | - |
| 71 | SYRE | Spyre Therapeutics, Inc. | 2.86B | 2.36% | 91,800 | - |
| 72 | APLS | Apellis Pharmaceuticals, Inc. | 2.81B | 2.83% | 289,715 | 1.02B |
| 73 | BEAM | Beam Therapeutics Inc. | 2.75B | 1.46% | 200,963 | 55.70M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.71B | 0.42% | 85,286 | 218.71M |
| 75 | VRDN | Viridian Therapeutics, Inc. | 2.71B | 0.39% | 355,113 | 70.79M |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.70B | 1.39% | 57,150 | 366.10M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.60B | 1.25% | 209,031 | 435.83M |
| 78 | IMNM | Immunome, Inc. | 2.53B | 0.99% | 136,211 | 9.68M |
| 79 | DYN | Dyne Therapeutics, Inc. | 2.52B | 0.20% | 210,915 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.51B | 1.48% | 188,970 | - |
| 81 | ADPT | Adaptive Biotechnologies Corporation | 2.45B | 0.70% | 258,029 | 276.98M |
| 82 | WVE | Wave Life Sciences Ltd. | 2.40B | 3.97% | 735,728 | 109.23M |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.39B | 0.42% | 170,563 | 240.00M |
| 84 | MAZE | Maze Therapeutics, Inc. | 2.29B | 1.13% | 56,391 | 2.50M |
| 85 | ZLAB | Zai Lab Limited | 2.24B | -0.42% | 70,185 | 441.63M |
| 86 | MESO | Mesoblast Limited | 2.22B | 2.37% | 36,108 | 17.20M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | 0.54% | 103,381 | - |
| 88 | GLPG | Galapagos NV | 2.22B | 1.65% | 65,726 | 336.64M |
| 89 | AAPG | Ascentage Pharma Group International | 2.20B | -2.00% | 622 | 54.52M |
| 90 | TLX | Telix Pharmaceuticals Limited | 2.12B | - | 59,735 | 664.23M |
| 91 | DNTH | Dianthus Therapeutics, Inc. | 2.12B | -0.33% | 26,661 | 3.08M |
| 92 | SLNO | Soleno Therapeutics, Inc. | 2.07B | 0.18% | 106,205 | 98.68M |
| 93 | NKTR | Nektar Therapeutics | 2.04B | -1.14% | 181,807 | 62.60M |
| 94 | NUVB | Nuvation Bio Inc. | 2.03B | 0.68% | 561,425 | 26.75M |
| 95 | HRMY | Harmony Biosciences Holdings, Inc. | 2.00B | -5.97% | 669,794 | 825.94M |
| 96 | RARE | Ultragenyx Pharmaceutical Inc. | 1.93B | -0.55% | 478,111 | 673.00M |
| 97 | VCEL | Vericel Corporation | 1.91B | 2.53% | 37,524 | 258.72M |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | 1.79% | 276,282 | 2.41B |
| 99 | MBX | MBX Biosciences, Inc. | 1.89B | 1.98% | 198,113 | - |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.89B | 0.35% | 64,010 | 265.81M |
| 101 | GLTO | Galecto, Inc. | 1.85B | 2.82% | 47,052 | - |
| 102 | STOK | Stoke Therapeutics, Inc. | 1.80B | 1.54% | 71,655 | 205.63M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | 1.60% | 214,168 | 111.30M |
| 104 | OLMA | Olema Pharmaceuticals, Inc. | 1.79B | 0.66% | 134,676 | - |
| 105 | RAPT | RAPT Therapeutics, Inc. | 1.79B | -0.05% | 239,563 | - |
| 106 | MANE | Veradermics, Incorporated | 1.78B | 0.72% | 67,574 | - |
| 107 | PGEN | Precigen, Inc. | 1.78B | -3.65% | 1,261,257 | 6.31M |
| 108 | INVA | Innoviva, Inc. | 1.77B | -0.48% | 68,544 | 388.52M |
| 109 | PHVS | Pharvaris N.V. | 1.77B | 2.33% | 6,447 | - |
| 110 | TNGX | Tango Therapeutics, Inc. | 1.76B | 2.11% | 498,445 | 66.50M |
| 111 | DFTX | Definium Therapeutics, Inc. | 1.74B | 4.67% | 372,334 | - |
| 112 | ZYME | Zymeworks Inc. | 1.73B | 0.35% | 71,679 | 134.48M |
| 113 | SION | Sionna Therapeutics, Inc. | 1.71B | 0.66% | 13,724 | - |
| 114 | MNKD | MannKind Corporation | 1.71B | 0.36% | 261,887 | 313.79M |
| 115 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -5.78% | 20,363,359 | 43.69M |
| 116 | OCS | Oculis Holding AG | 1.66B | -0.38% | 39,290 | 992.00K |
| 117 | IMCR | Immunocore Holdings plc | 1.65B | 1.11% | 190,903 | 379.59M |
| 118 | ARDX | Ardelyx, Inc. | 1.65B | 0.30% | 373,985 | 398.23M |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.64B | 2.17% | 152,611 | 83.98M |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -0.58% | 110,302 | 54.03M |
| 121 | ORKA | Oruka Therapeutics, Inc. | 1.61B | 1.87% | 36,632 | - |
| 122 | RLAY | Relay Therapeutics, Inc. | 1.59B | - | 195,196 | 8.36M |
| 123 | ELVN | Enliven Therapeutics, Inc. | 1.57B | 1.03% | 56,281 | - |
| 124 | TYRA | Tyra Biosciences, Inc. | 1.56B | 0.36% | 392,875 | - |
| 125 | BHVN | Biohaven Ltd. | 1.56B | 2.09% | 205,344 | - |
| 126 | QURE | uniQure N.V. | 1.55B | 14.16% | 955,966 | 15.75M |
| 127 | CLDX | Celldex Therapeutics, Inc. | 1.54B | 1.13% | 54,864 | 2.60M |
| 128 | ANAB | AnaptysBio, Inc. | 1.53B | 2.95% | 42,404 | 169.47M |
| 129 | ATAI | AtaiBeckley Inc. | 1.50B | 8.68% | 2,006,928 | 3.02M |
| 130 | OCUL | Ocular Therapeutix, Inc. | 1.50B | -1.57% | 3,210,383 | 51.95M |
| 131 | CRVS | Corvus Pharmaceuticals, Inc. | 1.47B | 0.63% | 148,515 | - |
| 132 | KOD | Kodiak Sciences Inc. | 1.47B | 4.46% | 98,020 | - |
| 133 | NTLA | Intellia Therapeutics, Inc. | 1.47B | 3.52% | 514,550 | 57.53M |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | 1.46B | 0.33% | 105,858 | 181.54M |
| 135 | ZBIO | Zenas BioPharma, Inc. | 1.46B | 1.31% | 99,489 | 15.00M |
| 136 | NVAX | Novavax, Inc. | 1.42B | 1.27% | 396,355 | 1.06B |
| 137 | SVRA | Savara Inc. | 1.40B | -1.40% | 132,658 | - |
| 138 | RAPP | Rapport Therapeutics, Inc. | 1.38B | -0.45% | 16,869 | - |
| 139 | IMTX | Immatics N.V. | 1.34B | 1.01% | 22,799 | 99.45M |
| 140 | SEPN | Septerna, Inc. | 1.34B | -1.16% | 74,494 | 22.05M |
| 141 | TRVI | Trevi Therapeutics, Inc. | 1.32B | 1.67% | 189,974 | - |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.32B | 5.82% | 599,766 | - |
| 143 | CAPR | Capricor Therapeutics, Inc. | 1.31B | 10.01% | 739,248 | 11.13M |
| 144 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | 3.28% | 545,577 | 6.31M |
| 145 | NBTX | Nanobiotix S.A. | 1.28B | 0.91% | 5,388 | 11.93M |
| 146 | DAWN | Day One Biopharmaceuticals, Inc. | 1.23B | 0.67% | 333,386 | 133.67M |
| 147 | EYPT | EyePoint, Inc. | 1.21B | -2.01% | 633,602 | 42.34M |
| 148 | DBVT | DBV Technologies S.A. | 1.21B | 1.79% | 35,365 | 5.50M |
| 149 | IVA | Inventiva S.A. | 1.18B | 2.30% | 33,277 | 19.93M |
| 150 | XERS | Xeris Biopharma Holdings, Inc. | 1.17B | 1.81% | 170,731 | 266.14M |
| 151 | GERN | Geron Corporation | 1.16B | 1.39% | 2,913,879 | 183.40M |
| 152 | CMPX | Compass Therapeutics, Inc. | 1.16B | 2.50% | 251,609 | 850.00K |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.15B | 0.75% | 45,747 | 1.40M |
| 154 | PHAR | Pharming Group N.V. | 1.11B | 3.53% | 14,044 | 362.27M |
| 155 | VIR | Vir Biotechnology, Inc. | 1.08B | 3.13% | 301,977 | 16.86M |
| 156 | IOVA | Iovance Biotherapeutics, Inc. | 1.06B | 2.10% | 1,203,505 | 250.43M |
| 157 | SANA | Sana Biotechnology, Inc. | 1.04B | 1.04% | 260,274 | - |
| 158 | ORIC | ORIC Pharmaceuticals, Inc. | 1.01B | 3.17% | 187,951 | - |
| 159 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 1.02% | 76,861 | 147.19M |
| 160 | GHRS | GH Research PLC | 1.00B | 1.06% | 12,399 | - |
| 161 | VTYX | Ventyx Biosciences, Inc. | 1.00B | 0.04% | 476,311 | - |
| 162 | URGN | UroGen Pharma Ltd. | 1.00B | 3.79% | 141,741 | 96.52M |
| 163 | EVMN | Evommune, Inc. | 991.20M | 0.78% | 92,800 | 13.00M |
| 164 | TBPH | Theravance Biopharma, Inc. | 961.26M | 0.85% | 65,169 | 80.33M |
| 165 | ABCL | AbCellera Biologics Inc. | 957.87M | 0.95% | 524,331 | 35.33M |
| 166 | VALN | Valneva SE | 952.30M | 2.78% | 6,453 | 211.09M |
| 167 | AVBP | ArriVent BioPharma, Inc. | 948.65M | 0.88% | 29,948 | - |
| 168 | SPRY | ARS Pharmaceuticals, Inc. | 937.08M | 1.07% | 105,233 | 142.77M |
| 169 | PVLA | Palvella Therapeutics, Inc. | 934.85M | -1.39% | 27,540 | - |
| 170 | FTRE | Fortrea Holdings Inc. | 932.32M | 4.02% | 412,358 | 2.76B |
| 171 | AKTS | Aktis Oncology, Inc. | 932.27M | -1.11% | 9,945 | 5.56M |
| 172 | SGP | SpyGlass Pharma, Inc. | 926.56M | 0.43% | 11,291 | - |
| 173 | CTMX | CytomX Therapeutics, Inc. | 898.85M | 0.66% | 243,422 | 113.63M |
| 174 | EIKN | Eikon Therapeutics, Inc. | 864.83M | 1.91% | 59,355 | - |
| 175 | OMER | Omeros Corporation | 845.13M | -0.08% | 165,239 | - |
| 176 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 843.88M | -1.03% | 55,777 | - |
| 177 | DRUG | Bright Minds Biosciences Inc. | 822.32M | 0.20% | 4,901 | - |
| 178 | XNCR | Xencor, Inc. | 821.93M | -0.26% | 126,039 | 150.13M |
| 179 | ABUS | Arbutus Biopharma Corporation | 817.38M | 1.92% | 356,107 | 14.61M |
| 180 | JANX | Janux Therapeutics, Inc. | 803.57M | 1.14% | 88,148 | 10.00M |
| 181 | BCAX | Bicara Therapeutics Inc. | 789.41M | 2.34% | 91,909 | - |
| 182 | KALV | KalVista Pharmaceuticals, Inc. | 779.93M | 2.94% | 170,171 | 1.43M |
| 183 | ANNX | Annexon, Inc. | 769.13M | 2.38% | 253,838 | - |
| 184 | MDXG | MiMedx Group, Inc. | 768.65M | 0.58% | 84,736 | 393.44M |
| 185 | MRVI | Maravai LifeSciences Holdings, Inc. | 764.56M | 2.05% | 80,279 | 192.44M |
| 186 | MPLT | MapLight Therapeutics, Inc. | 759.80M | 0.93% | 11,227 | - |
| 187 | ARVN | Arvinas, Inc. | 758.49M | 3.23% | 91,489 | 312.30M |
| 188 | GYRE | Gyre Therapeutics, Inc. | 753.48M | 0.97% | 14,977 | 107.27M |
| 189 | CGEM | Cullinan Therapeutics, Inc. | 741.41M | 2.95% | 214,509 | - |
| 190 | KURA | Kura Oncology, Inc. | 739.65M | 0.24% | 297,141 | 104.03M |
| 191 | FULC | Fulcrum Therapeutics, Inc. | 736.56M | 4.74% | 121,280 | 80.00M |
| 192 | AGMB | AgomAb Therapeutics NV | 699.86M | -5.21% | 38,801 | - |
| 193 | JBIO | Jade Biosciences, Inc. | 680.86M | 6.44% | 37,257 | - |
| 194 | REPL | Replimune Group, Inc. | 676.27M | 12.81% | 1,393,317 | - |
| 195 | ENGN | enGene Holdings Inc. | 663.15M | 0.10% | 16,026 | - |
| 196 | RIGL | Rigel Pharmaceuticals, Inc. | 647.28M | 0.31% | 36,662 | 282.08M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 639.48M | 0.54% | 65,628 | - |
| 198 | YDES | YD Bio Limited | 633.23M | 3.74% | 10,530 | 510.36K |
| 199 | SLS | SELLAS Life Sciences Group, Inc. | 630.04M | 1.09% | 694,115 | - |
| 200 | PROK | ProKidney Corp. | 628.74M | 3.47% | 101,110 | 744.00K |
| 201 | MGTX | MeiraGTx Holdings plc | 609.32M | -0.13% | 67,021 | 27.42M |
| 202 | LBRX | LB Pharmaceuticals Inc | 607.94M | -0.37% | 28,143 | - |
| 203 | NMRA | Neumora Therapeutics, Inc. | 605.83M | 0.71% | 289,139 | - |
| 204 | PRME | Prime Medicine, Inc. | 594.85M | 1.51% | 244,555 | 5.98M |
| 205 | ANRO | Alto Neuroscience, Inc. | 587.15M | -1.87% | 34,649 | - |
| 206 | DSGN | Design Therapeutics, Inc. | 586.16M | 1.68% | 28,012 | - |
| 207 | LXRX | Lexicon Pharmaceuticals, Inc. | 576.56M | 2.27% | 466,828 | 70.86M |
| 208 | CRMD | CorMedix Inc. | 568.46M | 0.07% | 284,472 | 214.30M |
| 209 | ALT | Altimmune, Inc. | 558.53M | -0.89% | 526,018 | 20.00K |
| 210 | VOR | Vor Biopharma Inc. | 558.03M | 3.54% | 107,644 | - |
| 211 | CTNM | Contineum Therapeutics, Inc. | 555.25M | 3.47% | 21,750 | - |
| 212 | FBRX | Forte Biosciences, Inc. | 533.87M | 0.54% | 15,703 | - |
| 213 | TENX | Tenax Therapeutics, Inc. | 531.47M | 4.97% | 14,484 | - |
| 214 | ADCT | ADC Therapeutics SA | 522.14M | 0.84% | 88,056 | 75.21M |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 521.19M | 1.89% | 229,936 | 180.61M |
| 216 | GOSS | Gossamer Bio, Inc. | 506.89M | 1.86% | 1,767,505 | 44.05M |
| 217 | KROS | Keros Therapeutics, Inc. | 503.60M | 0.06% | 51,896 | 246.72M |
| 218 | PRTA | Prothena Corporation plc | 495.24M | 2.68% | 82,658 | 11.79M |
| 219 | FDMT | 4D Molecular Therapeutics, Inc. | 492.23M | 1.79% | 117,011 | 120.00K |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 488.10M | 0.93% | 181,951 | 84.39M |
| 221 | ALLO | Allogene Therapeutics, Inc. | 487.66M | 0.46% | 1,540,415 | 22.00K |
| 222 | OCGN | Ocugen, Inc. | 480.36M | 1.74% | 547,023 | 5.37M |
| 223 | VTVT | vTv Therapeutics Inc. | 472.96M | 3.24% | 4,730 | 17.00K |
| 224 | LYEL | Lyell Immunopharma, Inc. | 469.07M | -13.00% | 88,804 | 41.00K |
| 225 | LXEO | Lexeo Therapeutics, Inc. | 467.12M | 1.91% | 105,692 | - |
| 226 | DMAC | DiaMedica Therapeutics Inc. | 465.33M | -0.17% | 27,842 | - |
| 227 | PEPG | PepGen Inc. | 461.30M | -1.18% | 30,955 | - |
| 228 | VSTM | Verastem, Inc. | 455.37M | 0.68% | 336,311 | 13.38M |
| 229 | ZURA | Zura Bio Limited | 454.61M | 0.98% | 24,190 | - |
| 230 | ASMB | Assembly Biosciences, Inc. | 453.95M | 3.16% | 10,079 | 37.19M |
| 231 | UPB | Upstream Bio, Inc. | 452.84M | 0.60% | 730,491 | 2.80M |
| 232 | IVVD | Invivyd, Inc. | 451.18M | 3.23% | 267,654 | 50.04M |
| 233 | SLDB | Solid Biosciences Inc. | 449.54M | 4.91% | 701,715 | - |
| 234 | KYTX | Kyverna Therapeutics, Inc. | 439.90M | 1.45% | 85,663 | - |
| 235 | IMMX | Immix Biopharma, Inc. | 428.41M | 0.12% | 127,391 | - |
| 236 | NAGE | Niagen Bioscience, Inc. | 422.07M | 0.19% | 136,277 | 124.71M |
| 237 | PRTC | PureTech Health plc | 421.77M | - | 50 | 6.39M |
| 238 | TECX | Tectonic Therapeutic, Inc. | 418.68M | 6.07% | 27,947 | - |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 417.61M | 0.12% | 1,443 | - |
| 240 | LENZ | LENZ Therapeutics, Inc. | 414.59M | 1.61% | 174,889 | 17.50M |
| 241 | AUTL | Autolus Therapeutics plc | 411.19M | 2.32% | 382,834 | 51.13M |
| 242 | RGNX | REGENXBIO Inc. | 411.06M | 1.00% | 124,588 | 161.32M |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 410.62M | 2.09% | 18,319 | 66.98M |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 409.56M | 0.60% | 74,934 | 10.82M |
| 245 | TRDA | Entrada Therapeutics, Inc. | 409.18M | 3.54% | 21,023 | 61.52M |
| 246 | ABSI | Absci Corporation | 406.00M | 1.50% | 664,984 | 2.82M |
| 247 | IMMP | Immutep Limited | 400.78M | 1.99% | 20,792 | 3.31M |
| 248 | AVXL | Anavex Life Sciences Corp. | 380.42M | 1.61% | 200,078 | - |
| 249 | RZLT | Rezolute, Inc. | 377.06M | - | 346,750 | - |
| 250 | NBP | NovaBridge Biosciences | 374.70M | 0.93% | 35,861 | - |
| 251 | IPSC | Century Therapeutics, Inc. | 371.87M | 7.25% | 209,096 | 113.34M |
| 252 | BCYC | Bicycle Therapeutics plc | 369.04M | 1.72% | 58,767 | 28.34M |
| 253 | MNPR | Monopar Therapeutics Inc. | 369.01M | 1.85% | 56,973 | - |
| 254 | HELP | Cybin Inc. | 368.76M | 9.02% | 312,910 | - |
| 255 | ANL | Adlai Nortye Ltd. | 367.90M | 3.64% | 51,088 | -1.35M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 365.79M | 2.11% | 239,836 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 365.63M | 1.74% | 104,315 | - |
| 258 | VNDA | Vanda Pharmaceuticals Inc. | 364.11M | -0.65% | 182,650 | 216.11M |
| 259 | GLSI | Greenwich LifeSciences, Inc. | 362.43M | 3.65% | 32,973 | - |
| 260 | BNTC | Benitec Biopharma Inc. | 360.88M | 1.74% | 11,656 | - |
| 261 | TARA | Protara Therapeutics, Inc. | 360.11M | 2.60% | 74,365 | - |
| 262 | NAUT | Nautilus Biotechnology, Inc. | 351.76M | 3.53% | 169,633 | - |
| 263 | ACRS | Aclaris Therapeutics, Inc. | 351.04M | -0.61% | 90,645 | 15.74M |
| 264 | PBYI | Puma Biotechnology, Inc. | 342.16M | 0.59% | 41,122 | 212.00M |
| 265 | IMRX | Immuneering Corporation | 333.50M | 0.88% | 59,098 | - |
| 266 | FHTX | Foghorn Therapeutics Inc. | 330.69M | 1.53% | 33,334 | 24.52M |
| 267 | AURA | Aura Biosciences, Inc. | 321.96M | -3.43% | 44,431 | - |
| 268 | CADL | Candel Therapeutics, Inc. | 316.76M | 2.49% | 137,567 | - |
| 269 | ALDX | Aldeyra Therapeutics, Inc. | 311.64M | 0.58% | 178,237 | - |
| 270 | XOMA | XOMA Royalty Corporation | 305.37M | 0.78% | 16,147 | 47.11M |
| 271 | FENC | Fennec Pharmaceuticals Inc. | 303.28M | 2.30% | 7,106 | 38.79M |
| 272 | ARMP | Armata Pharmaceuticals, Inc. | 299.99M | 1.10% | 7,692 | 5.05M |
| 273 | ALXO | ALX Oncology Holdings Inc. | 295.19M | -0.88% | 37,664 | - |
| 274 | CABA | Cabaletta Bio, Inc. | 293.61M | 3.04% | 559,545 | - |
| 275 | STRO | Sutro Biopharma, Inc. | 287.77M | 5.56% | 33,395 | 105.65M |
| 276 | RLMD | Relmada Therapeutics, Inc. | 287.47M | 7.69% | 152,681 | - |
| 277 | NERV | Minerva Neurosciences, Inc. | 285.61M | 2.33% | 25,085 | - |
| 278 | CLLS | Cellectis S.A. | 281.86M | 3.87% | 3,133 | 82.55M |
| 279 | AVTX | Avalo Therapeutics, Inc. | 278.89M | -0.03% | 16,988 | 192.00K |
| 280 | AARD | Aardvark Therapeutics, Inc. | 274.67M | 1.33% | 3,480 | - |
| 281 | ABEO | Abeona Therapeutics Inc. | 274.48M | 0.50% | 61,699 | 400.00K |
| 282 | NGNE | Neurogene Inc. | 272.62M | 1.27% | 9,177 | 925.00K |
| 283 | CLYM | Climb Bio, Inc. | 265.43M | -0.90% | 40,045 | - |
| 284 | IRD | Opus Genetics, Inc. | 265.17M | -1.16% | 137,707 | 14.63M |
| 285 | LRMR | Larimar Therapeutics, Inc. | 263.62M | 1.65% | 80,365 | - |
| 286 | XFOR | X4 Pharmaceuticals, Inc. | 259.69M | -4.19% | 373,705 | 33.98M |
| 287 | STTK | Shattuck Labs, Inc. | 258.81M | 2.25% | 129,571 | 1.00M |
| 288 | ACIU | AC Immune SA | 257.25M | -10.65% | 406,119 | 5.48M |
| 289 | ENLV | Enlivex Therapeutics Ltd. | 256.37M | -1.82% | 23,382 | - |
| 290 | PALI | Palisade Bio, Inc. | 251.07M | -0.88% | 647,238 | - |
| 291 | OABI | OmniAb, Inc. | 246.88M | 0.29% | 55,662 | 21.09M |
| 292 | CHRS | Coherus Oncology, Inc. | 243.64M | 1.24% | 371,089 | 277.73M |
| 293 | IKT | Inhibikase Therapeutics, Inc. | 239.37M | 3.55% | 168,702 | 1.00 |
| 294 | NVCT | Nuvectis Pharma, Inc. | 236.84M | 0.22% | 4,382 | - |
| 295 | SLN | Silence Therapeutics plc | 235.23M | -0.60% | 32,937 | 25.83M |
| 296 | PLX | Protalix BioTherapeutics, Inc. | 234.03M | -2.35% | 551,563 | 61.84M |
| 297 | HRTX | Heron Therapeutics, Inc. | 224.62M | 2.94% | 198,336 | 155.10M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 223.60M | 3.13% | 25,607 | 2.82M |
| 299 | CNTX | Context Therapeutics Inc. | 223.27M | 4.29% | 345,465 | - |
| 300 | ACHV | Achieve Life Sciences, Inc. | 222.52M | -1.42% | 53,938 | - |
| 301 | MDWD | MediWound Ltd. | 221.81M | -2.37% | 39,403 | 20.93M |
| 302 | CAMP | Camp4 Therapeutics Corporation | 218.68M | 3.82% | 6,226 | 3.80M |
| 303 | ARCT | Arcturus Therapeutics Holdings Inc. | 216.52M | 2.97% | 67,930 | 97.60M |
| 304 | ALEC | Alector, Inc. | 215.03M | - | 173,264 | 69.05M |
| 305 | SRZN | Surrozen, Inc. | 210.51M | 0.12% | 5,669 | 3.60M |
| 306 | HUMA | Humacyte, Inc. | 210.37M | -4.39% | 1,350,952 | 1.57M |
| 307 | SLGL | Sol-Gel Technologies Ltd. | 206.15M | 0.27% | 3,595 | 18.97M |
| 308 | CBUS | Cibus, Inc. | 203.34M | -7.67% | 400,966 | 3.79M |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 194.72M | -0.13% | 44,773 | 10.30M |
| 310 | VYGR | Voyager Therapeutics, Inc. | 191.54M | 1.03% | 55,696 | 31.32M |
| 311 | OVID | Ovid Therapeutics Inc. | 190.10M | 2.11% | 72,506 | 6.61M |
| 312 | GALT | Galectin Therapeutics Inc. | 187.29M | 6.02% | 28,745 | - |
| 313 | CCCC | C4 Therapeutics, Inc. | 185.11M | 4.37% | 269,311 | 30.11M |
| 314 | CBIO | Crescent Biopharma, Inc. | 183.77M | 0.75% | 31,951 | - |
| 315 | SABS | SAB Biotherapeutics, Inc. | 179.00M | -3.09% | 31,900 | 114.70K |
| 316 | MOLN | Molecular Partners AG | 177.03M | -0.42% | 268 | 856.30K |
| 317 | NTHI | NeOnc Technologies Holdings, Inc. | 177.02M | -1.84% | 26,360 | 59.99K |
| 318 | TLSA | Tiziana Life Sciences Ltd | 175.48M | -1.08% | 40,669 | - |
| 319 | MIST | Milestone Pharmaceuticals Inc. | 173.20M | 0.29% | 189,239 | - |
| 320 | PRLD | Prelude Therapeutics Incorporated | 173.03M | -0.47% | 16,062 | 10.50M |
| 321 | KPTI | Karyopharm Therapeutics Inc. | 172.43M | - | 132,233 | 146.07M |
| 322 | ELDN | Eledon Pharmaceuticals, Inc. | 171.80M | 2.61% | 78,420 | - |
| 323 | CNTB | Connect Biopharma Holdings Limited | 171.06M | 7.75% | 87,576 | 762.00K |
| 324 | SGMT | Sagimet Biosciences Inc. | 170.74M | 1.94% | 90,241 | - |
| 325 | KLRS | Kalaris Therapeutics, Inc. | 170.19M | 10.10% | 33,830 | - |
| 326 | EDIT | Editas Medicine, Inc. | 169.86M | - | 177,832 | 46.38M |
| 327 | RNAC | Cartesian Therapeutics, Inc. | 166.68M | -5.04% | 53,775 | 1.09M |
| 328 | RANI | Rani Therapeutics Holdings, Inc. | 161.71M | 3.96% | 75,507 | 1.20M |
| 329 | ZNTL | Zentalis Pharmaceuticals, Inc. | 160.26M | 4.87% | 65,034 | 26.87M |
| 330 | PRQR | ProQR Therapeutics N.V. | 160.12M | 4.83% | 81,493 | 18.86M |
| 331 | IPHA | Innate Pharma S.A. | 159.81M | 1.18% | 1,284 | 14.84M |
| 332 | CGEN | Compugen Ltd. | 157.61M | 0.30% | 23,835 | 6.90M |
| 333 | FATE | Fate Therapeutics, Inc. | 157.46M | 1.87% | 471,225 | 7.14M |
| 334 | ADAG | Adagene Inc. | 157.18M | 1.37% | 2,603 | 103.20K |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 155.07M | 4.49% | 70,095 | - |
| 336 | NKTX | Nkarta, Inc. | 152.00M | 3.88% | 77,239 | - |
| 337 | ELTX | Elicio Therapeutics, Inc. | 150.98M | 0.58% | 9,321 | - |
| 338 | PMN | ProMIS Neurosciences, Inc. | 149.27M | 2.94% | 6,629 | - |
| 339 | CRBU | Caribou Biosciences, Inc. | 147.68M | 1.94% | 131,752 | 9.30M |
| 340 | MENS | Jyong Biotech Ltd. | 143.03M | 8.77% | 85,503 | - |
| 341 | WHWK | Whitehawk Therapeutics, Inc. | 140.91M | 1.70% | 6,938 | 14.38M |
| 342 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 139.43M | 0.07% | 11,930 | - |
| 343 | TNYA | Tenaya Therapeutics, Inc. | 137.31M | 0.48% | 1,175,795 | - |
| 344 | PLYX | Polaryx Therapeutics, Inc. | 136.35M | -27.27% | 1,091,489 | - |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 136.04M | 1.77% | 56,126 | - |
| 346 | SGMO | Sangamo Therapeutics, Inc. | 134.18M | -2.43% | 2,221,519 | 32.88M |
| 347 | SPRO | Spero Therapeutics, Inc. | 133.52M | 0.85% | 67,397 | 40.55M |
| 348 | VXRT | Vaxart, Inc. | 131.99M | -1.15% | 43,499 | 148.20M |
| 349 | ORMP | Oramed Pharmaceuticals Inc. | 130.15M | 2.19% | 68,474 | 2.00M |
| 350 | BDTX | Black Diamond Therapeutics, Inc. | 129.33M | 1.79% | 55,626 | 70.00M |
| 351 | ACOG | Alpha Cognition Inc. | 120.67M | 6.53% | 63,041 | 7.43M |
| 352 | GNLX | Genelux Corporation | 115.58M | 1.95% | 7,429 | 8.00K |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 113.70M | 1.53% | 100,593 | 182.34K |
| 354 | SEER | Seer, Inc. | 110.53M | -4.15% | 87,985 | 16.38M |
| 355 | COYA | Coya Therapeutics, Inc. | 109.62M | 0.54% | 7,913 | 3.99M |
| 356 | FBIO | Fortress Biotech, Inc. | 109.13M | 0.45% | 45,193 | 62.30M |
| 357 | MGNX | MacroGenics, Inc. | 108.80M | 1.18% | 62,025 | 127.63M |
| 358 | CRDF | Cardiff Oncology, Inc. | 108.79M | 3.53% | 56,589 | 501.00K |
| 359 | KRRO | Korro Bio, Inc. | 107.35M | -0.71% | 12,163 | 7.37M |
| 360 | ONCY | Oncolytics Biotech Inc. | 107.12M | 1.85% | 264,058 | - |
| 361 | CDXS | Codexis, Inc. | 106.58M | -2.48% | 98,254 | 52.93M |
| 362 | IMUX | Immunic, Inc. | 106.48M | -3.50% | 563,771 | - |
| 363 | ARTV | Artiva Biotherapeutics, Inc. | 104.81M | 3.89% | 15,402 | 251.00K |
| 364 | DWTX | Dogwood Therapeutics, Inc. | 104.55M | 4.67% | 3,450 | - |
| 365 | AGEN | Agenus Inc. | 103.73M | - | 112,346 | 106.83M |
| 366 | VANI | Vivani Medical, Inc. | 103.01M | 2.38% | 45,096 | - |
| 367 | SAVA | Cassava Sciences, Inc. | 102.41M | 1.44% | 56,209 | - |
| 368 | CGTX | Cognition Therapeutics, Inc. | 101.07M | 2.23% | 110,807 | - |
| 369 | ACTU | Actuate Therapeutics, Inc. | 100.64M | 1.64% | 8,095 | - |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 97.70M | 10.89% | 238,801 | 30.83M |
| 371 | TTRX | Turn Therapeutics Inc. | 97.46M | 3.44% | 1,586 | - |
| 372 | EQ | Equillium, Inc. | 97.44M | 0.64% | 22,191 | 4.39M |
| 373 | ATYR | aTyr Pharma, Inc. | 97.37M | 1.09% | 549,047 | 190.00K |
| 374 | ANIX | Anixa Biosciences, Inc. | 96.30M | 0.17% | 18,280 | - |
| 375 | DTIL | Precision BioSciences, Inc. | 94.60M | -1.50% | 24,126 | 698.00K |
| 376 | BMEA | Biomea Fusion, Inc. | 92.27M | -1.88% | 139,607 | - |
| 377 | OKYO | OKYO Pharma Limited | 89.90M | - | 26,753 | - |
| 378 | PYXS | Pyxis Oncology, Inc. | 85.99M | 3.83% | 105,402 | 2.82M |
| 379 | CSBR | Champions Oncology, Inc. | 82.62M | 1.71% | 3,187 | 58.42M |
| 380 | EXOZ | eXoZymes, Inc. | 81.83M | -2.58% | 28 | -700.00 |
| 381 | IBIO | iBio, Inc. | 81.18M | 2.62% | 84,326 | 300.00K |
| 382 | PYPD | PolyPid Ltd. | 80.10M | -0.23% | 8,705 | - |
| 383 | MCRB | Seres Therapeutics, Inc. | 79.07M | 5.56% | 16,189 | 351.00K |
| 384 | MNOV | MediciNova, Inc. | 78.63M | - | 13,395 | 257.92K |
| 385 | MAIA | MAIA Biotechnology, Inc. | 75.00M | -0.51% | 85,475 | - |
| 386 | PLRX | Pliant Therapeutics, Inc. | 74.35M | 7.08% | 479,032 | - |
| 387 | XBIT | XBiotech Inc. | 71.80M | 0.64% | 1,290 | - |
| 388 | IMA | ImageneBio, Inc. | 71.36M | 2.45% | 26,124 | 800.00K |
| 389 | GANX | Gain Therapeutics, Inc. | 71.15M | 2.21% | 152,038 | - |
| 390 | ACET | Adicet Bio, Inc. | 71.05M | -0.14% | 73,427 | - |
| 391 | MREO | Mereo BioPharma Group plc | 68.36M | 3.34% | 1,122,187 | 500.00K |
| 392 | NBY | NovaBay Pharmaceuticals, Inc. | 67.81M | -3.87% | 336,655 | 10.30M |
| 393 | HURA | TuHURA Biosciences, Inc. | 67.40M | -1.77% | 236,318 | - |
| 394 | HYFT | MindWalk Holdings Corp. | 67.00M | 3.99% | 50,529 | 19.02M |
| 395 | ENTX | Entera Bio Ltd. | 66.95M | 2.82% | 44,887 | 124.00K |
| 396 | ETHZ | ETHZilla Corporation | 66.92M | 0.28% | 115,502 | 4.11M |
| 397 | SPRB | Spruce Biosciences, Inc. | 66.82M | 7.19% | 196,071 | 697.00K |
| 398 | COEP | Coeptis Therapeutics Holdings, Inc. | 66.00M | -3.17% | 20,023 | 501.00K |
| 399 | ANVS | Annovis Bio, Inc. | 65.20M | 3.36% | 61,753 | - |
| 400 | GUTS | Fractyl Health, Inc. | 63.10M | 4.76% | 478,894 | 3.00K |
| 401 | GRCE | Grace Therapeutics, Inc. | 61.97M | 1.65% | 25,973 | - |
| 402 | ATHE | Alterity Therapeutics Limited | 61.46M | - | 167 | 3.57M |
| 403 | KZIA | Kazia Therapeutics Limited | 59.38M | 2.06% | 99,380 | 1.20M |
| 404 | IFRX | InflaRx N.V. | 59.31M | 3.08% | 49,914 | 73.73K |
| 405 | PTHS | Pelthos Therapeutics Inc. | 58.85M | - | 392 | 7.41M |
| 406 | ICCC | ImmuCell Corporation | 58.33M | 3.33% | 823 | 27.77M |
| 407 | TIL | Instil Bio, Inc. | 58.22M | -0.06% | 12,959 | - |
| 408 | LPCN | Lipocine Inc. | 57.91M | 10.37% | 32,000 | 4.32M |
| 409 | QTTB | Q32 Bio Inc. | 57.84M | -3.27% | 19,692 | - |
| 410 | PMVP | PMV Pharmaceuticals, Inc. | 57.47M | 1.89% | 21,288 | - |
| 411 | NRXS | NeurAxis, Inc. | 57.31M | -0.19% | 28,417 | 3.36M |
| 412 | MGX | Metagenomi Therapeutics, Inc. | 55.57M | 1.37% | 21,674 | 30.91M |
| 413 | TCRX | TScan Therapeutics, Inc. | 55.33M | -0.02% | 34,034 | 8.42M |
| 414 | RADX | Radiopharm Theranostics Limited | 55.08M | 2.30% | 2,418 | 8.20M |
| 415 | TVGN | Tevogen Bio Holdings Inc. | 54.35M | -2.32% | 122,968 | - |
| 416 | NRXP | NRx Pharmaceuticals, Inc. | 54.18M | 1.67% | 96,105 | 242.00K |
| 417 | ESLA | Estrella Immunopharma, Inc. | 53.80M | - | 3,319 | - |
| 418 | BYSI | BeyondSpring Inc. | 53.46M | - | 3,688 | 1.88M |
| 419 | INKT | MiNK Therapeutics, Inc. | 52.06M | -0.81% | 875 | - |
| 420 | NTRB | Nutriband Inc. | 52.03M | 0.12% | 3,249 | 2.28M |
| 421 | ACRV | Acrivon Therapeutics, Inc. | 50.80M | 0.63% | 139,066 | - |
| 422 | PSTV | Plus Therapeutics, Inc. | 49.00M | -1.21% | 785,311 | 5.26M |
| 423 | KZR | Kezar Life Sciences, Inc. | 47.23M | 2.06% | 28,578 | - |
| 424 | IBO | Impact BioMedical Inc. | 46.49M | 1.00% | 3,082 | 25.00K |
| 425 | CRVO | CervoMed Inc. | 45.29M | 7.82% | 39,118 | 6.16M |
| 426 | NXTC | NextCure, Inc. | 45.19M | -2.42% | 778 | - |
| 427 | CING | Cingulate Inc. | 44.06M | - | 79,276 | - |
| 428 | APLM | Apollomics, Inc. | 43.18M | -0.54% | 3,834 | 6.93M |
| 429 | LONA | LeonaBio, Inc. | 42.57M | 3.87% | 3,203 | - |
| 430 | ALGS | Aligos Therapeutics, Inc. | 42.46M | 3.29% | 8,523 | 2.65M |
| 431 | OSTX | OS Therapies Incorporated | 41.73M | -2.07% | 82,877 | - |
| 432 | XLO | Xilio Therapeutics, Inc. | 41.48M | 1.40% | 56,570 | 31.80M |
| 433 | CVM | CEL-SCI Corporation | 41.03M | 2.09% | 8,113 | - |
| 434 | LITS | Lite Strategy, Inc. | 40.81M | 0.91% | 145,676 | - |
| 435 | LSTA | Lisata Therapeutics, Inc. | 40.22M | - | 24,157 | 1.07M |
| 436 | TELO | Telomir Pharmaceuticals, Inc. | 39.54M | - | 17,085 | - |
| 437 | ABVC | ABVC BioPharma, Inc. | 39.51M | -1.84% | 10,518 | 797.92K |
| 438 | INMB | INmune Bio Inc. | 39.21M | 5.36% | 59,668 | 50.00K |
| 439 | VERU | Veru Inc. | 39.21M | 3.95% | 17,871 | 16.89M |
| 440 | PLUR | Pluri Inc. | 38.19M | 2.43% | 9,394 | 1.34M |
| 441 | RNXT | RenovoRx, Inc. | 37.75M | 5.10% | 55,569 | 928.00K |
| 442 | PDSB | PDS Biotechnology Corporation | 37.65M | 1.47% | 40,024 | - |
| 443 | CELU | Celularity Inc. | 37.49M | 1.56% | 8,072 | 40.58M |
| 444 | ATOS | Atossa Therapeutics, Inc. | 37.46M | 4.82% | 14,695 | - |
| 445 | JSPR | Jasper Therapeutics, Inc. | 36.38M | 7.44% | 356,689 | - |
| 446 | SNSE | Sensei Biotherapeutics, Inc. | 36.29M | 215.12% | 6,748,735 | - |
| 447 | TVRD | Tvardi Therapeutics, Inc. | 34.80M | 1.64% | 3,307 | - |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 33.69M | - | 24,753 | 90.00K |
| 449 | OKUR | OnKure Therapeutics, Inc. | 33.19M | 2.08% | 43,815 | - |
| 450 | ATRA | Atara Biotherapeutics, Inc. | 33.09M | 2.23% | 22,190 | 151.93M |
| 451 | HOWL | Werewolf Therapeutics, Inc. | 32.28M | 0.96% | 56,719 | 1.14M |
| 452 | HYPD | Hyperion DeFi, Inc. | 32.16M | 1.06% | 25,699 | 345.32K |
| 453 | TPST | Tempest Therapeutics, Inc. | 31.25M | -1.77% | 7,505 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 30.97M | 4.46% | 811 | 8.30M |
| 455 | LTRN | Lantern Pharma Inc. | 30.87M | 0.76% | 6,090 | - |
| 456 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 30.82M | -0.21% | 464,087 | - |
| 457 | PTN | Palatin Technologies, Inc. | 29.94M | 1.25% | 6,967 | 8.96M |
| 458 | DYAI | Dyadic International, Inc. | 29.85M | 2.48% | 124,676 | 3.34M |
| 459 | RNTX | Rein Therapeutics Inc. | 29.84M | -1.30% | 31,984 | - |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 29.81M | -10.75% | 589,190 | - |
| 461 | OTLK | Outlook Therapeutics, Inc. | 29.19M | -5.97% | 640,309 | 205.54K |
| 462 | ANTX | AN2 Therapeutics, Inc. | 29.05M | 0.95% | 22,701 | - |
| 463 | BCTX | BriaCell Therapeutics Corp. | 28.67M | 0.25% | 37,918 | - |
| 464 | PASG | Passage Bio, Inc. | 28.51M | 1.76% | 1,095 | - |
| 465 | CUE | Cue Biopharma, Inc. | 26.91M | 1.31% | 54,068 | 7.10M |
| 466 | EVAX | Evaxion A/S | 26.86M | 1.90% | 5,566 | 7.65M |
| 467 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.75M | 1.66% | 8,100 | - |
| 468 | IOBT | IO Biotech, Inc. | 26.32M | -0.05% | 213,249 | - |
| 469 | BOLD | Boundless Bio, Inc. | 26.19M | 1.74% | 16,033 | - |
| 470 | SKYE | Skye Bioscience, Inc. | 25.80M | 8.77% | 94,597 | - |
| 471 | AEON | AEON Biopharma, Inc. | 25.75M | 4.92% | 13,246 | - |
| 472 | MRKR | Marker Therapeutics, Inc. | 24.68M | 2.07% | 5,430 | 4.69M |
| 473 | XCUR | Exicure, Inc. | 24.51M | -1.03% | 4,819 | 500.00K |
| 474 | IGC | IGC Pharma, Inc. | 24.48M | -0.20% | 84,480 | 1.11M |
| 475 | DARE | Daré Bioscience, Inc. | 23.86M | - | 7,819 | -57.13K |
| 476 | BRNS | Barinthus Biotherapeutics plc | 23.74M | -5.31% | 96,487 | 14.97M |
| 477 | SNTI | Senti Biosciences, Inc. | 23.18M | 2.74% | 30,665 | - |
| 478 | NEUP | Neuphoria Therapeutics Inc. | 23.07M | 5.42% | 26,906 | 14.99M |
| 479 | PLRZ | Polyrizon Ltd. | 22.71M | 2.52% | 7,687 | - |
| 480 | RLYB | Rallybio Corporation | 22.71M | -0.69% | 16,536 | 674.00K |
| 481 | NNVC | NanoViricides, Inc. | 21.57M | -2.91% | 369,072 | - |
| 482 | VTGN | Vistagen Therapeutics, Inc. | 20.90M | -0.49% | 90,339 | 789.00K |
| 483 | GNTA | Genenta Science S.p.A. | 20.78M | -1.44% | 27,868 | - |
| 484 | VYNE | VYNE Therapeutics Inc. | 19.72M | -0.17% | 49,347 | 524.00K |
| 485 | ANEB | Anebulo Pharmaceuticals, Inc. | 19.25M | -1.87% | 1,858 | - |
| 486 | JUNS | Jupiter Neurosciences, Inc. | 18.59M | -3.54% | 14,914 | - |
| 487 | SER | Serina Therapeutics, Inc. | 18.01M | 1.21% | 59,817 | 116.00K |
| 488 | INAB | IN8bio, Inc. | 17.09M | 1.74% | 801 | - |
| 489 | CASI | CASI Pharmaceuticals, Inc. | 16.93M | - | 3,032 | 26.85M |
| 490 | FBLG | FibroBiologics, Inc. | 16.72M | -0.24% | 74,100 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 16.58M | -0.09% | 40,641 | 3.94M |
| 492 | TRAW | Traws Pharma, Inc. | 16.46M | 5.10% | 24,524 | 2.85M |
| 493 | LEXX | Lexaria Bioscience Corp. | 16.18M | 0.06% | 15,208 | 522.00K |
| 494 | KLTO | Klotho Neurosciences, Inc. | 16.18M | 1.85% | 408,320 | - |
| 495 | KTTA | Pasithea Therapeutics Corp. | 16.16M | 1.05% | 7,859 | - |
| 496 | MBRX | Moleculin Biotech, Inc. | 15.64M | 11.40% | 232,940 | - |
| 497 | HOTH | Hoth Therapeutics, Inc. | 15.41M | 1.26% | 116,984 | - |
| 498 | CRIS | Curis, Inc. | 14.86M | 2.37% | 6,474 | 11.65M |
| 499 | QNTM | Quantum BioPharma Ltd. | 14.74M | -4.31% | 29,363 | - |
| 500 | ALLR | Allarity Therapeutics, Inc. | 14.15M | 6.02% | 50,352 | - |
| 501 | INTS | Intensity Therapeutics, Inc. | 13.85M | -2.10% | 627,831 | - |
| 502 | LNAI | Lunai Bioworks Inc. | 13.67M | -15.28% | 147,782 | - |
| 503 | CLRB | Cellectar Biosciences, Inc. | 13.32M | 0.71% | 12,278 | - |
| 504 | COCP | Cocrystal Pharma, Inc. | 12.82M | 0.01% | 2,392 | - |
| 505 | PHIO | Phio Pharmaceuticals Corp. | 12.81M | -19.05% | 1,607,893 | - |
| 506 | BLRX | BioLineRx Ltd. | 12.64M | 1.42% | 791 | 12.74M |
| 507 | ITRM | Iterum Therapeutics plc | 12.63M | -6.71% | 383,775 | 390.00K |
| 508 | MLEC | Moolec Science SA | 12.62M | 81.42% | 3,389,876 | 7.83M |
| 509 | GTBP | GT Biopharma, Inc. | 12.53M | 2.84% | 416,544 | - |
| 510 | NCEL | NewcelX Ltd. | 12.44M | 0.74% | 1,237 | - |
| 511 | BCDA | BioCardia, Inc. | 12.20M | -1.29% | 7,285 | 3.00K |
| 512 | KAPA | Kairos Pharma, Ltd. | 11.97M | -2.36% | 8,340 | - |
| 513 | CVKD | Cadrenal Therapeutics, Inc. | 11.78M | 2.65% | 5,683 | - |
| 514 | LGVN | Longeveron Inc. | 11.57M | -1.67% | 7,005 | 1.44M |
| 515 | KALA | KALA BIO, Inc. | 11.35M | 0.90% | 74,609 | - |
| 516 | SNGX | Soligenix, Inc. | 11.30M | 0.90% | 19,909 | 2.34K |
| 517 | IMNN | Imunon, Inc. | 11.23M | 1.62% | 2,886 | - |
| 518 | AKTX | Akari Therapeutics, Plc | 11.09M | 0.41% | 36,590 | - |
| 519 | OSRH | OSR Holdings, Inc. | 11.03M | -6.48% | 231,690 | -90.52K |
| 520 | GDTC | CytoMed Therapeutics Limited | 10.96M | -7.77% | 36,180 | 573.19K |
| 521 | BCAB | BioAtla, Inc. | 10.25M | -2.27% | 1,197,232 | 11.00M |
| 522 | QNCX | Quince Therapeutics, Inc. | 10.11M | -1.84% | 18,526,601 | - |
| 523 | CLGN | CollPlant Biotechnologies Ltd. | 10.08M | 10.41% | 88,663 | 2.48M |
| 524 | GRDX | GridAI Technologies Corp. | 9.98M | 1.71% | 11,544 | - |
| 525 | BIVI | BioVie Inc. | 9.92M | 2.73% | 22,319 | - |
| 526 | BOLT | Bolt Biotherapeutics, Inc. | 9.79M | 2.00% | 6,640 | 5.20M |
| 527 | ERNA | Ernexa Therapeutics Inc. | 9.60M | 7.39% | 1,315,774 | 1,000.00 |
| 528 | PULM | Pulmatrix, Inc. | 9.42M | 6.61% | 10,418 | 3.00K |
| 529 | PHGE | BiomX Inc. | 9.29M | -1.19% | 36,962 | - |
| 530 | ICU | SeaStar Medical Holding Corporation | 8.91M | 2.13% | 35,037 | 881.00K |
| 531 | CMMB | Chemomab Therapeutics Ltd. | 8.86M | -4.64% | 95,190 | - |
| 532 | EDSA | Edesa Biotech, Inc. | 8.75M | 2.24% | 44,496 | - |
| 533 | NCNA | NuCana plc | 8.74M | 5.00% | 10,677 | - |
| 534 | XTLB | XTL Biopharmaceuticals Ltd. | 8.55M | 4.76% | 102,099 | 968.00K |
| 535 | CALC | CalciMedica, Inc. | 8.47M | -4.08% | 88,877 | - |
| 536 | RNAZ | TransCode Therapeutics, Inc. | 8.43M | 6.12% | 8,753 | - |
| 537 | EVGN | Evogene Ltd. | 8.39M | -4.66% | 23,401 | 8.02M |
| 538 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.97M | 6.03% | 9,309 | - |
| 539 | KPRX | Kiora Pharmaceuticals, Inc. | 7.45M | 0.50% | 6,326 | 20.00K |
| 540 | ADXN | Addex Therapeutics Ltd | 7.34M | - | 186 | 198.82K |
| 541 | ASBP | Aspire Biopharma Holdings, Inc. | 7.29M | -8.81% | 101,005 | 1.94K |
| 542 | APVO | Aptevo Therapeutics Inc. | 7.00M | -1.82% | 3,016 | - |
| 543 | LIMN | Liminatus Pharma, Inc. | 6.99M | 0.74% | 3,289,630 | - |
| 544 | ALZN | Alzamend Neuro, Inc. | 6.84M | 9.09% | 156,408 | - |
| 545 | TOVX | Theriva Biologics, Inc. | 6.78M | 5.15% | 6,003,386 | - |
| 546 | REVB | Revelation Biosciences, Inc. | 6.74M | 1.43% | 45,758 | - |
| 547 | IMRN | Immuron Limited | 6.67M | 5.10% | 1,280 | 4.78M |
| 548 | PMCB | PharmaCyte Biotech, Inc. | 6.59M | -0.23% | 8,266 | - |
| 549 | APM | Aptorum Group Limited | 6.51M | 1.39% | 1,394 | - |
| 550 | CELZ | Creative Medical Technology Holdings, Inc. | 6.40M | - | 318 | 6.00K |
| 551 | MBIO | Mustang Bio, Inc. | 6.37M | -1.96% | 7,299 | - |
| 552 | CANF | Can-Fite BioPharma Ltd. | 6.02M | 0.91% | 991 | 560.00K |
| 553 | PPBT | Purple Biotech Ltd | 6.00M | 0.85% | 36,782 | - |
| 554 | CLDI | Calidi Biotherapeutics, Inc. | 5.85M | 6.53% | 29,071 | - |
| 555 | BRTX | BioRestorative Therapies, Inc. | 5.80M | 1.31% | 2,870,401 | 383.40K |
| 556 | TCRT | Alaunos Therapeutics, Inc. | 5.78M | 0.39% | 317 | 6.00K |
| 557 | MTVA | MetaVia Inc. | 5.36M | 8.44% | 72,034 | - |
| 558 | XBIO | Xenetic Biosciences, Inc. | 5.22M | 4.59% | 11,954 | 2.86M |
| 559 | BGMS | Bio Green Med Solution, Inc. | 5.15M | 1.94% | 6,334 | 81.00K |
| 560 | VIVS | VivoSim Labs, Inc. | 5.09M | 1.56% | 11,986 | 142.00K |
| 561 | SLXN | Silexion Therapeutics Corp | 5.05M | 2.22% | 4,154 | - |
| 562 | ACXP | Acurx Pharmaceuticals, Inc. | 5.02M | -0.50% | 4,244 | - |
| 563 | GOVX | GeoVax Labs, Inc. | 4.94M | 18.99% | 222,764 | 3.35M |
| 564 | APRE | Aprea Therapeutics, Inc. | 4.91M | 17.02% | 3,294,138 | 488.24K |
| 565 | PCSA | Processa Pharmaceuticals, Inc. | 4.87M | -1.38% | 3,456 | - |
| 566 | CYCN | Cyclerion Therapeutics, Inc. | 4.83M | 2.42% | 18,718 | 2.86M |
| 567 | DCOY | Decoy Therapeutics Inc. | 4.62M | -3.57% | 6,517 | - |
| 568 | GNPX | Genprex, Inc. | 4.34M | 3.89% | 44,011 | - |
| 569 | MTNB | Matinas BioPharma Holdings, Inc. | 4.10M | 4.89% | 3,810 | - |
| 570 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.05M | -1.87% | 18,603 | 1.36M |
| 571 | INDP | Indaptus Therapeutics, Inc. | 4.04M | -0.55% | 606 | - |
| 572 | SILO | Silo Pharma, Inc. | 3.80M | -5.78% | 2,808,659 | 72.10K |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 3.75M | -0.16% | 23,754 | - |
| 574 | GRI | GRI Bio, Inc. | 3.45M | 3.46% | 22,879 | - |
| 575 | ENVB | Enveric Biosciences, Inc. | 3.10M | 7.21% | 61,165 | - |
| 576 | DRMA | Dermata Therapeutics, Inc. | 3.05M | 1.59% | 20,911 | - |
| 577 | ADIL | Adial Pharmaceuticals, Inc. | 3.04M | 1.48% | 8,926 | - |
| 578 | JAGX | Jaguar Health, Inc. | 2.95M | 5.40% | 152,624 | 11.79M |
| 579 | OGEN | Oragenics, Inc. | 2.94M | 8.00% | 30,607 | - |
| 580 | PPCB | Propanc Biopharma, Inc. | 2.94M | - | 110,466 | - |
| 581 | PBM | Psyence Biomedical Ltd. | 2.84M | -0.36% | 3,872 | - |
| 582 | SPRC | SciSparc Ltd. | 2.83M | -3.32% | 21,820 | 1.31M |
| 583 | SCNI | Scinai Immunotherapeutics Ltd. | 2.66M | - | 2,424 | 1.15M |
| 584 | CDIO | Cardio Diagnostics Holdings, Inc. | 2.59M | 19.33% | 22,718 | 15.78K |
| 585 | XRTX | XORTX Therapeutics Inc. | 2.55M | -5.49% | 7,340 | - |
| 586 | LYRA | Lyra Therapeutics, Inc. | 2.48M | 3.70% | 5,232 | 600.00K |
| 587 | CDT | CDT Equity Inc. | 2.42M | -4.55% | 10,762 | - |
| 588 | ARTL | Artelo Biosciences, Inc. | 2.22M | -2.65% | 3,714 | - |
| 589 | BBLG | Bone Biologics Corporation | 2.05M | 1.79% | 10,447 | - |
| 590 | CNSP | CNS Pharmaceuticals, Inc. | 2.00M | -1.23% | 7,698 | - |
| 591 | CMND | Clearmind Medicine Inc. | 1.83M | 0.83% | 53,670 | - |
| 592 | AZTR | Azitra, Inc. | 1.76M | -3.14% | 588,331 | 7.50K |
| 593 | HCWB | HCW Biologics Inc. | 1.59M | -2.18% | 29,474 | 422.03K |
| 594 | VRAX | Virax Biolabs Group Limited | 1.52M | 2.45% | 35,976 | 2.99K |
| 595 | ELAB | PMGC Holdings Inc. | 1.51M | -0.80% | 100,476 | 285.95K |
| 596 | ABP | Abpro Holdings, Inc. | 1.49M | -7.92% | 145,520 | 183.00K |
| 597 | ENSC | Ensysce Biosciences, Inc. | 1.33M | -15.39% | 1,382,259 | 4.49M |
| 598 | ONCO | Onconetix, Inc. | 1.14M | -6.35% | 68,982 | 1.22M |
| 599 | ADTX | Aditxt, Inc. | 1.10M | 1.56% | 25,737 | 5.95K |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 1.07M | -1.54% | 50,688 | 104.90K |